| Subject: | FDA Issues Nationwide Notification of Recall Certain Guidant Implantable Defibrillators and Cardiac Resynchronization Therapy Defibrillators |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Tue, 21 Jun 2005 - 10:00 am |
| The FDA is notifying healthcare providers and patients that Guidant Corporation is recalling the following implantable defibrillators and cardiac resynchronization therapy defibrillators.
Products affected:
PRIZM 2 DR, Model 1861, manufactured on or before April 16, 2002 -CONTAK RENEWAL, Model H135, manufactured on or before August 26, 2004 -CONTAK RENEWAL 2, Model H155, manufactured on or before August 26, 2004
The above listed devices... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
Customizable Documents and Tools:
Related MCN Products:
|
|
StayAlert! notifies healthcare customers of all federal and regulatory body legislation changes impacting the healthcare industry, including TJC (JCAHO), CDC, CMS, DHHS, FDA, OSHA, OIG and many others. StayAlert! complements this with regulatory implementation action plans. StayAlert! serves as a virtual healthcare department, augmenting traditional employee staffed departments and freeing employees to perform other vital functions. The strength of StayAlert! rests in its ability to allow healthcare organizations to streamline their businesses using the Internet as a foundation architecture. StayAlert! provides cost containment and reduction through elimination of unnecessary overhead, and work caused by errors or poor access to information. |
|
